Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06949059
PHASE1/PHASE2

Intravenous Hydromorphone for the Treatment of Acute Pain

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

View on ClinicalTrials.gov

Summary

To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.

Official title: Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain: A Single-Center, Prospective, Single-Arm Study

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-01-01

Completion Date

2027-12-31

Last Updated

2025-11-17

Healthy Volunteers

No

Interventions

DRUG

Hydromorphone

Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time.

Locations (1)

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China